Seth B. Coffelt - Concepedia

Author

Seth B. Coffelt

Also Known As

Coffelt, Seth B., K Van De Vijver, S B Coffelt, S Coffelt, S. B. Coffelt, S. Coffelt, SB Coffelt, Seth B Coffelt, Seth B. Coffelt, Seth B. Coffelt (156668)

249

Publications

11.1K

Citations

H-Index

Concepts

All Affiliations

University of Glasgow Cancer Research UK Scotland Institute University of Sheffield Tulane University The Netherlands Cancer Institute

About

Seth B. Coffelt is an author at University of Glasgow specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	3.9K
2	Immunology	13	14	3.7K
3	Cell Biology	12	12	3.2K
4	Health Sciences	2	2	348
5	Neurology	1	1	39

Seth B. Coffelt

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis Seth B. Coffelt, Kelly Kersten, Chris W. Doornebal, Nature Breast Cancer MetastasisCancer ImmunosurveillanceLymphocyte DevelopmentImmune RegulationImmunology	2015	1.7K
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis Max D. Wellenstein, Seth B. Coffelt, Danique E. M. Duits, Nature InflammationBreast Cancer MetastasisBreast OncologyMedicineImmunology	2019	484
Toll-Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses Suzanne L. Tomchuck, Kevin J. Zwezdaryk, Seth B. Coffelt, Stem Cells	2007	450
Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions Seth B. Coffelt, Andrea O. Tal, Alexander Scholz, Cancer Research Human TemsImmunologyPathologyCancer BiologyTumor Biology	2010	328
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia Hsin‐Yu Fang, Russell Hughes, Craig Murdoch, Blood	2009	318
The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells Seth B. Coffelt, Frank C. Marini, Keri L. Watson, Proceedings of the National Academy of Sciences Msc MigrationImmunologyGynecologyCancer BiologyTumor Biology	2009	281
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice Abigail Welford, Daniela Biziato, Seth B. Coffelt, Journal of Clinical Investigation ImmunologyMetronomic ChemotherapyTumor BiologyInflammationAngiogenesis	2011	228
Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion Seth B. Coffelt, Yung‐Yi Chen, Munitta Muthana, The Journal of Immunology Angpt2-stimulated ReleaseT-regulatory CellImmunologyImmunotherapyTumor Angiogenesis	2011	209
Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma Nathiya Muthalagu, Tiziana Monteverde, Ximena L. Raffo Iraolagoitia, Cancer Discovery	2020	165
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response Camilla Salvagno, Metamia Ciampricotti, Sander Tuit, Nature Cell Biology InflammationCytokineMedicineImmunologyTumor Immunity	2019	160

Page 1